过去一年中添加的文章,按日期排序
Idiopathic hyalinizing fibrosclerosis: A systemic steroid-resistant condition distinct from IgG4-related disease
Y Zen, D Joshi - Human Pathology, 2024 - Elsevier
9 天前 - … and mediastinal fibrosis was made, they were treated with a … In conclusion, a
hyalinizing fibrotic condition can occur at … the hepatic hilum also shows broad scarring fibrosis with …
hyalinizing fibrotic condition can occur at … the hepatic hilum also shows broad scarring fibrosis with …
[HTML][HTML] The evolution and revolution of artificial intelligence in hepatology: From current applications to future paradigms
C Simsek - Hepatology Forum, 2024 - ncbi.nlm.nih.gov
49 天前 - … in patients with hepatic encephalopathy, outperforming … treatment strategies beyond
initial diagnosis. AI-based decision-making tools improve adjuvant liver-directed treatment …
initial diagnosis. AI-based decision-making tools improve adjuvant liver-directed treatment …
The Pan-PPAR Agonist Lanifibranor Reverses Metabolic Dysfunction in People with Type 2 Diabetes and MASLD: A Randomised, Double-Blind, Placebo-Controlled …
D Barb, S Kalavalapalli, E Godinez Leiva, F Bril… - papers.ssrn.com
84 天前 - … Lanifibranor treatment significantly improved both hepatic and peripheral insulin …
In summary, a treatment centred on a pan-PPAR approach offered significant hepatic and …
In summary, a treatment centred on a pan-PPAR approach offered significant hepatic and …
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
M Huttasch, M Roden, S Kahl - Metabolism, 2024 - Elsevier
92 天前 - … induced by different MASLD treatments and their association … development directly
targeting hepatic lipid metabolism (… improve hepatic outcomes, MASLD treatment concepts …
targeting hepatic lipid metabolism (… improve hepatic outcomes, MASLD treatment concepts …
[HTML][HTML] Management of Liver Cirrhosis and Its Complications
Z Wu, L Chen, J Chen, C Chen - 2024 - intechopen.com
96 天前 - … This process also stimulates the proliferation of hepatic venous … treatment can
alleviate liver fibrosis, reduce portal vein pressure, and reverse the progression of liver fibrosis …
alleviate liver fibrosis, reduce portal vein pressure, and reverse the progression of liver fibrosis …
Oral delivery of ferroptosis inducers for effective treatment of hepatic fibrosis
Y Yu, S Zhang, Y Xu, H Shao, L Luo - Nano Research, 2024 - Springer
106 天前 - … relieving liver fibrosis. This work provides a proof-ofconcept demonstration that
an oral delivery strategy for ferroptosis inducers may be beneficial for liver fibrosis treatment. …
an oral delivery strategy for ferroptosis inducers may be beneficial for liver fibrosis treatment. …
[引用][C] Can dietary gluten restriction improve hepatic steatosis? Authors' reply
A Armandi, D Schuppan… - Alimentary …, 2024 - Wiley Online Library
107 天前 - … to see that this marker of hepatic fibrogenesis was improving (median difference−
0.6, p… might include the concept of a gluten (ATI)-free diet for the treatment of MASLD. Through …
0.6, p… might include the concept of a gluten (ATI)-free diet for the treatment of MASLD. Through …
Este oare posibilă recompensarea în ciroza hepatică virală?
E Cebanu - Arta Medica, 2024 - ibn.idsi.md
111 天前 - … fibrosis and its reversal, which can be used as potential treatment targets to inhibit
fibrosis, … [25] consideră că țesutul fibros hepatic poate manifesta posibilități de degradare. …
fibrosis, … [25] consideră că țesutul fibros hepatic poate manifesta posibilități de degradare. …
Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis
TM Bentsa - INTERNATIONAL JOURNAL OF …, 2024 - iej.zaslavsky.com.ua
124 天前 - … and gut dysbiosis exacerbate hepatic and systemic inflammation due to … treatment
is performed mainly in patients with nonalcoholic steatohepatitis and biopsy-proven fibrosis, …
is performed mainly in patients with nonalcoholic steatohepatitis and biopsy-proven fibrosis, …
Cirrhotic cardiomyopathy: a subject that's always topical
M Boudabbous, R Hammemi, H Gdoura… - Future Science …, 2024 - Taylor & Francis
188 天前 - … Cirrhosis is the final stage in the development of hepatic fibrosis in chronic liver
disease… this entity, there is no specific treatment available for cirrhotic cardiomyopathy. The …
disease… this entity, there is no specific treatment available for cirrhotic cardiomyopathy. The …